This educational activity is intended for physicians (MDs/DOs), advanced practice professionals (nurse practitioners and physician associates), pharmacists, and nurses who care for patients with obesity or overweight, including those specializing in endocrinology, obesity medicine, and primary care.

Upon completion of the activity, participants should be able to:

• Describe obesity as a chronic progressive disease characterized by adipose tissue dysfunction and chronic low-grade inflammation, which together contribute to metabolic complications
• Recognize the effects of current obesity medications on obesity-related inflammation and comorbidities
• Describe how amylin physiology relates to obesity
• Analyze the potential role of amylin-based therapies in future obesity treatment

There are no fees for participating and receiving credit for this activity. Successful completion is achieved by reviewing the CE information and completing both the activity and the evaluation form.

Credit Fulfillment
If you are requesting AMA credits, ANCC credits, or a certificate of participation, your certificate will be available for download.

This activity is jointly provided by The France Foundation and the American Association of Immunologists.

In support of improving patient care, this activity has been planned and implemented by The France Foundation and the American Association of Immunologists. The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.

PHYSICIAN CREDIT DESIGNATION
The France Foundation designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES
The France Foundation designates this activity for 1.5 contact hours.

All other health care professionals completing this course will be issued a statement of participation.

This activity is supported by an educational grant from Novo Nordisk.

Your registration, attendance at, and/or participation in this meeting constitutes consent to being photographed, videotaped, or recorded during the meeting by The France Foundation, its educational collaborators, or anyone authorized on behalf of these organizations. You further authorize, without any compensation paid to you, the use of any photographs, videos, or recordings that contain your likeness, image, or voice in any educational, informational, commercial, or promotional materials produced and/or distributed by The France Foundation, its educational collaborators, or anyone authorized by these organizations, as well as on any internet sites maintained by any of these entities. Images/recordings used for these purposes will not be sold, and no personal information about you or the subject (other than event location and date) will be included in the production of any material.